AMPH
NASD Amphastar Pharmaceuticals, Inc.$25.87 ↑ +0.00 (+0.00%) Trading Up from the previous close of $25.87, $0.74 below the day’s high of $26.61
- YTD change
- -3.40%
- vs 20-day SMA
- +0.47%
- vs 200-day SMA
- +15.87%
Price ranges
Price & Performance
+4.06 (+18.62%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 61.8% away from all-time highs of $67.66
- AMPH is down 3% since the beginning of the year
- AMPH is up 11% over the past 12 months
- AMPH is up 9% over the past 1 month
- 14% of all AMPH investors are betting against AMPH
AMPH reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +11.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +0.23%
- vs 8-day SMA
- -1.07%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredients. It operates through Pharmaceutical Products segment. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.